FI970244A0 - Menetelmä vakiinnuttaa toonisen munasarjaestrogeenin erittyminen jatkettuja hoitotapoja varten - Google Patents

Menetelmä vakiinnuttaa toonisen munasarjaestrogeenin erittyminen jatkettuja hoitotapoja varten

Info

Publication number
FI970244A0
FI970244A0 FI970244A FI970244A FI970244A0 FI 970244 A0 FI970244 A0 FI 970244A0 FI 970244 A FI970244 A FI 970244A FI 970244 A FI970244 A FI 970244A FI 970244 A0 FI970244 A0 FI 970244A0
Authority
FI
Finland
Prior art keywords
therapies
secretion
continued
ovarian estrogen
method stabilizes
Prior art date
Application number
FI970244A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI970244A (fi
Inventor
Gary D Hodgen
Audrey Philips
Original Assignee
Hampton Roads Medical College
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26959766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI970244(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/467,860 external-priority patent/US5658884A/en
Application filed by Hampton Roads Medical College, Ortho Pharma Corp filed Critical Hampton Roads Medical College
Publication of FI970244A publication Critical patent/FI970244A/fi
Publication of FI970244A0 publication Critical patent/FI970244A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI970244A 1994-07-22 1997-01-21 Menetelmä vakiinnuttaa toonisen munasarjaestrogeenin erittyminen jatkettuja hoitotapoja varten FI970244A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27959394A 1994-07-22 1994-07-22
US08/467,860 US5658884A (en) 1994-07-22 1995-06-06 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
PCT/US1995/008996 WO1996003138A1 (en) 1994-07-22 1995-07-18 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens

Publications (2)

Publication Number Publication Date
FI970244A FI970244A (fi) 1997-01-21
FI970244A0 true FI970244A0 (fi) 1997-01-21

Family

ID=26959766

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970244A FI970244A0 (fi) 1994-07-22 1997-01-21 Menetelmä vakiinnuttaa toonisen munasarjaestrogeenin erittyminen jatkettuja hoitotapoja varten

Country Status (29)

Country Link
EP (1) EP0769956B1 (de)
JP (1) JP3138477B2 (de)
CN (1) CN1137722C (de)
AP (1) AP775A (de)
AT (1) ATE190494T1 (de)
AU (1) AU691952B2 (de)
BG (1) BG63363B1 (de)
BR (1) BR9508718A (de)
CA (1) CA2195745C (de)
CY (1) CY2228B1 (de)
CZ (1) CZ291803B6 (de)
DE (1) DE69515666T2 (de)
DK (1) DK0769956T3 (de)
EE (1) EE03515B1 (de)
ES (1) ES2145286T3 (de)
FI (1) FI970244A0 (de)
GR (1) GR3033590T3 (de)
HU (1) HU218910B (de)
IL (1) IL114655A (de)
IS (1) IS4413A (de)
LV (1) LV11823B (de)
MX (1) MX9700574A (de)
NO (1) NO970257L (de)
NZ (1) NZ290554A (de)
OA (1) OA10730A (de)
PT (1) PT769956E (de)
RU (1) RU2181598C2 (de)
SK (1) SK282118B6 (de)
WO (1) WO1996003138A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173592B1 (en) 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
EP1214086A2 (de) * 1999-09-23 2002-06-19 Zentaris AG Behandlung von endometriosis und eileiterverschluss
DE10137174A1 (de) * 2001-07-31 2003-02-13 Zentaris Ag Verwendung von LHRH-Antagonisten in nichtkastrierenden Dosen zur Verbesserung der T-Zellen-vermittelten Immunität
GB0616111D0 (en) * 2006-06-16 2006-09-20 Ardana Bioscience Ltd Agents, methods and uses
EP2095818A1 (de) * 2008-02-29 2009-09-02 AEterna Zentaris GmbH Verwendung von LHRH-Antagonisten in nicht-kastrierenden Dosen
WO2009145690A1 (en) * 2008-05-29 2009-12-03 Isr Immune System Regulation Ab Method and means for treating viral disease, in particular hiv/aids
EP3560555A1 (de) * 2018-04-26 2019-10-30 LifeArc Zusammensetzung zur behandlung einer oder mehrerer östrogenvermittelter krankheiten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171835A (en) * 1988-10-21 1992-12-15 The Administrators Of The Tulane Educational Fund LHRH antagonists
US5169932A (en) * 1989-10-30 1992-12-08 The Salk Institute For Biological Studies Gnrh analogs
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
US5681817A (en) * 1994-02-04 1997-10-28 The Medical College Of Hampton Roads Treatment of ovarian estrogen dependent conditions
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

Also Published As

Publication number Publication date
EE03515B1 (et) 2001-10-15
NO970257D0 (no) 1997-01-21
DK0769956T3 (da) 2000-06-05
HU218910B (hu) 2000-12-28
PT769956E (pt) 2000-07-31
FI970244A (fi) 1997-01-21
AP9700913A0 (en) 1997-01-31
CN1200674A (zh) 1998-12-02
AP775A (en) 1999-10-28
CN1137722C (zh) 2004-02-11
JP3138477B2 (ja) 2001-02-26
IS4413A (is) 1997-01-14
HU9700046D0 (en) 1997-02-28
BG101158A (en) 1997-09-30
SK7097A3 (en) 1997-11-05
NO970257L (no) 1997-01-21
IL114655A0 (en) 1995-11-27
BG63363B1 (bg) 2001-11-30
EE9700208A (et) 1998-02-16
MX9700574A (es) 1997-12-31
ES2145286T3 (es) 2000-07-01
WO1996003138A1 (en) 1996-02-08
CA2195745A1 (en) 1996-02-08
CZ15097A3 (en) 1997-11-12
HUT77127A (hu) 1998-03-02
JPH10503203A (ja) 1998-03-24
EP0769956A4 (de) 1999-03-10
GR3033590T3 (en) 2000-09-29
NZ290554A (en) 2000-08-25
EP0769956A1 (de) 1997-05-02
AU691952B2 (en) 1998-05-28
DE69515666T2 (de) 2000-07-06
EP0769956B1 (de) 2000-03-15
AU3132095A (en) 1996-02-22
LV11823A (lv) 1997-08-20
SK282118B6 (sk) 2001-11-06
LV11823B (en) 1998-03-20
DE69515666D1 (de) 2000-04-20
IL114655A (en) 2005-08-31
BR9508718A (pt) 1997-12-30
RU2181598C2 (ru) 2002-04-27
CZ291803B6 (cs) 2003-06-18
CA2195745C (en) 2005-03-29
OA10730A (en) 2001-06-07
CY2228B1 (en) 2003-04-18
ATE190494T1 (de) 2000-04-15

Similar Documents

Publication Publication Date Title
FI940374A0 (fi) Menetelmä väriaineiden virittämiseksi
NO953282D0 (no) Fremgangsmåte for bedring av produktiviteten til en brönn
FI921026A0 (fi) Menetelmä radiopuhelimen referenssitaajuuden stabiloimiseksi
DE69616022T2 (de) Frequenzsynthetisierer
NO971807L (no) To-trinns fremgangsmåte for separasjon
FI945343A0 (fi) Menetelmä ja kytkentä radiopuhelimen taajuuksien mMenetelmä ja kytkentä radiopuhelimen taajuuksien muodostamiseksi uodostamiseksi
NO983913D0 (no) Fremgangsmåte for oppfanging av tioler
FI970244A0 (fi) Menetelmä vakiinnuttaa toonisen munasarjaestrogeenin erittyminen jatkettuja hoitotapoja varten
FI963018A (fi) Menetelmä gammapyronien valmistamiseksi
ZA956099B (en) Method of establishing tonic ovarian estrogen secretion for extended therapeutic regimens.
FI952104A0 (fi) Menetelmä epäorgaanisten yhdisteiden jauheiden valmistamiseksi
FI972694A (fi) Uusi menetelmä sameridiinin valmistamiseksi
DE69523018T2 (de) Frequenzteiler
FI953291A (fi) Menetelmä meta- ja paraetyylifenolin erottamiseksi
FR2734957B1 (fr) Armement-traverse a fixation rapide pour travaux sous-tension
FI102975B (fi) Menetelmä hiokkeen valmistusprosessin ohjaamiseksi
FI954359A0 (fi) Menetelmä ja laite kaivon päiväaukon pienentämiseksi
KR950034488U (ko) 발진주파수 제어방법
KR960020187U (ko) 저주파 전침기
LV10943A (lv) N-benziloksikarbonilarginina 4-metilkumaril-7-amida iegusanas metode
UA26019C2 (uk) Спосіб підготовки кристалу до обточуваhhя
GB9604873D0 (en) Aid for cardiopulmonary resuscitation
FI944588A0 (fi) Menetelmä massan valmistamiseksi
SE9602598D0 (sv) Method of making powder mixtures
NO954108D0 (no) Fremgangsmåte for fremstilling av betong

Legal Events

Date Code Title Description
FC Application refused